Related Experiment Videos
Paroxysmal kinesigenic choreoathetosis and abnormal contingent negative variation. A case report
Archives of Neurology
|June 1, 1983
Summary
This study investigated paroxysmal kinesigenic choreoathetosis (PKC), a rare movement disorder. Findings suggest a link between abnormal contingent negative variation (CNV) and PKC, which improved with phenytoin sodium treatment.
Area of Science:
- Neuroscience
- Movement Disorders
- Clinical Electrophysiology
Background:
- Paroxysmal kinesigenic choreoathetosis (PKC) is a rare movement disorder with unclear etiology and pathophysiology.
- Anticipated movements exacerbate PKC symptoms, suggesting a role for predictive neural processes.
Observation:
- The study examined the contingent negative variation (CNV), a brain potential linked to anticipation, in a PKC patient.
- A significant enhancement of the slow negative wave (SNW), a CNV component, was observed in the patient compared to controls.
Findings:
- Phenytoin sodium therapy effectively reduced PKC attacks.
- Following treatment, the enhanced SNW amplitude in the patient normalized to control levels, indicating a potential biomarker.
Implications:
- This research suggests a neurophysiological link between abnormal CNV/SNW and paroxysmal kinesigenic choreoathetosis.
- The findings may guide future diagnostic approaches and therapeutic strategies for this rare movement disorder.